Dynavax Allergic Rhinitis TOLAMBA Trial
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 13 Feb 2007
At a glance
- Drugs Ragweed allergy immunotherapy 1018-ISS conjugate (Primary)
- Indications Seasonal allergic rhinitis
- Focus Registrational; Therapeutic Use
- Acronyms DARTT
- Sponsors Dynavax Technologies
- 13 Feb 2007 Interim 1-year results reported. Added to VAX.
- 26 Jun 2006 New trial record.